CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 10
Author(s): Gislaine Z. Réus
Affiliation:
Export Options
About this article
Cite this article as:
Réus Z. Gislaine , Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2019; 18 (10) . https://dx.doi.org/10.2174/187152731810200102104356
DOI https://dx.doi.org/10.2174/187152731810200102104356 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
19
5
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse
Current Neuropharmacology Interactions Between Nanosized Materials and the Brain
Current Medicinal Chemistry Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology Inhibitory Feature of the Proprotein Convertases Prosegments
Medicinal Chemistry The Neuroprotective Mechanism of Erythropoietin-TAT Fusion Protein Against Neurodegeneration from Ischemic Brain Injury
CNS & Neurological Disorders - Drug Targets Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Solvent-free Synthesis and Antimicrobial Properties of Some Novel Furanone and Spiropyrimidone Derivatives
Current Organic Synthesis Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms
Current Molecular Pharmacology Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases
CNS & Neurological Disorders - Drug Targets Functional Variants of the Interleukin-23 Receptor Gene in Non-Gastrointestinal Autoimmune Diseases
Current Medicinal Chemistry An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) Meet Our Editorial Board Member
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Conformational Flexibility in Designing Peptides for Immunology: The Molecular Dynamics Approach
Current Computer-Aided Drug Design Interleukin-10 and Articular Cartilage: Experimental Therapeutical Approaches in Cartilage Disorders
Current Gene Therapy Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design Tetralone Scaffolds and Their Potential Therapeutic Applications
Letters in Drug Design & Discovery IMGT Colliers de Perles: Standardized Sequence-Structure Representations of the IgSF and MhcSF Superfamily Domains
Current Bioinformatics Personality and Genetics
Current Psychiatry Reviews Neurobiological Consequences of Sleep Deprivation
Current Neuropharmacology